Kangji Medical Holdings Limited

HKEX:9997.HK

5.28 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017
Revenue 926.023786.367690.263511.49503.467353.67247.506
Cost of Revenue 184.824151.12127.33780.0280.29264.37347.801
Gross Profit 741.199635.247562.926431.47423.175289.297199.705
Gross Profit Ratio 0.80.8080.8160.8440.8410.8180.807
Reseach & Development Expenses 127.55466.01936.00125.2217.37714.85910.477
General & Administrative Expenses 100.26970.89262.0645.68825.57912.5888.072
Selling & Marketing Expenses 69.84253.37246.51548.89441.35520.50611.826
SG&A 170.111123.21109.18994.5826733.09419.898
Other Expenses -6.384-26.466-3.692-25.55-1.1550.061-3.718
Operating Expenses 240.221140.23179.818138.49748.67740.74534.514
Operating Income 442.47446.018417.736311.668338.798260.545162.64
Operating Income Ratio 0.4780.5670.6050.6090.6730.7370.657
Total Other Income Expenses Net 146.301117.126116.761-1.59352.3960.614-0.468
Income Before Tax 588.771563.144534.497310.075391.194261.159162.172
Income Before Tax Ratio 0.6360.7160.7740.6060.7770.7380.655
Income Tax Expense 136.476101.9777.70850.92564.45937.36623.695
Net Income 504.021478.735456.789250.296206.444146.701117.705
Net Income Ratio 0.5440.6090.6620.4890.410.4150.476
EPS 0.430.40.370.260.20.120.094
EPS Diluted 0.430.40.370.260.20.120.094
EBITDA 619.438460.532427.251319.142345.196266.806169.113
EBITDA Ratio 0.6690.5860.6190.6240.6860.7540.683